Nikhil Agarwal, MD
Gastroenterology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 3 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Agarwal’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A102503 · Current
Licensed to practise in California · since 2008 · expires 2027-07-31 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$125,647
Medicare paid this office $125,647 for 371 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 82 | $18,439 | $225 |
| Long return visit (40+ min) | 82 | $17,592 | $163 |
| Test for tone and sensation of rectum and anus | 32 | $17,098 | $534 |
| Imaging of digestive tract done from the inside of the digestive tract | 20 | $16,824 | $801 |
| Study of rectum sensitivity and function | 32 | $9,235 | $289 |
See all 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 82 | $18,439 | $225 |
| Long return visit (40+ min) | 82 | $17,592 | $163 |
| Test for tone and sensation of rectum and anus | 32 | $17,098 | $534 |
| Imaging of digestive tract done from the inside of the digestive tract | 20 | $16,824 | $801 |
| Study of rectum sensitivity and function | 32 | $9,235 | $289 |
| Biopsy of large bowel using a flexible endoscope | 71 | $6,955 | $98 |
| Return visit (30+ min) | 49 | $6,497 | $116 |
| Study of esophagus to assess movement | 21 | $4,468 | $213 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 63 | $4,343 | $67 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 21 | $3,712 | $177 |
| New patient visit (45+ min) | 25 | $3,287 | $131 |
| New patient visit (60+ min) | 12 | $2,090 | $174 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 18 | $1,906 | $100 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 84 | $373 | $4 |
Procedures Medicare counted
| Colonoscopy | 121 | More than 84% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 95 | More than 76% of doctors who do this |
Who their Medicare patients are
371 Original Medicare patients in 2024. Average age 74 · Under 65 4% · 85 and older 8% · Women 64% · Also on Medicaid 5% · Health risk score 1.00. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 56% · Coronary heart disease 21% · Diabetes 19% · Depression 17% · Chronic kidney disease 15% · Cancer 15% · Atrial fibrillation 15% · Heart failure 8% · COPD 8% · Dementia 3%.
The office billed $901,622, Medicare allowed $159,497 and paid $125,647; for 743 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 371 | 743 | 74 | 1.00 | $901,622 | $125,647 |
| 2023 | 350 | 717 | 74 | 0.85 | $743,858 | $108,730 |
| 2022 | 368 | 827 | 74 | 0.80 | $705,790 | $100,140 |
| 2021 | 316 | 678 | 73 | 0.83 | $620,557 | $89,390 |
| 2020 | 228 | 450 | 73 | 1.07 | $339,071 | $46,718 |
| 2019 | 313 | 590 | 72 | 1.06 | $511,263 | $66,226 |
| 2018 | 392 | 1,049 | 68 | 2.00 | $712,368 | $101,635 |
| 2017 | 423 | 1,198 | 68 | 2.01 | $861,162 | $117,427 |
| 2016 | 359 | 1,059 | 67 | 2.02 | $754,668 | $114,166 |
| 2015 | 345 | 1,007 | 67 | 2.03 | $629,911 | $118,224 |
| 2014 | 98 | 259 | 65 | 1.68 | $162,494 | $30,858 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Long return visit (40+ min) | 83 | $19,272 | $162 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | $17,667 | $236 |
| Test for tone and sensation of rectum and anus | 24 | $13,520 | $563 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $9,891 | $824 |
| Biopsy of large bowel using a flexible endoscope | 71 | $7,994 | $113 |
| Study of rectum sensitivity and function | 22 | $6,421 | $292 |
| Return visit (30+ min) | 37 | $4,755 | $113 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | $3,763 | $209 |
| New patient visit (45+ min) | 26 | $3,721 | $143 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $3,527 | $80 |
| New patient visit (60+ min) | 16 | $3,366 | $210 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 12 | $1,350 | $113 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $957 | $87 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 129 | $613 | $5 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 11 | $511 | $30 |
2022: 14 services
| Long return visit (40+ min) | 62 | $15,944 | $161 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 59 | $12,847 | $218 |
| Test for tone and sensation of rectum and anus | 21 | $12,406 | $591 |
| Biopsy of large bowel using a flexible endoscope | 96 | $11,353 | $118 |
| Return visit (30+ min) | 58 | $7,284 | $107 |
| Study of rectum sensitivity and function | 21 | $6,271 | $299 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,403 | $210 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $3,394 | $68 |
| New patient visit (45+ min) | 24 | $3,298 | $137 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 28 | $2,824 | $94 |
| New patient visit (60+ min) | 11 | $2,138 | $194 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 63 | $1,434 | $22 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 12 | $1,316 | $110 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 172 | $827 | $5 |
2021: 11 services
| Long return visit (40+ min) | 53 | $12,916 | $163 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 50 | $11,558 | $231 |
| Biopsy of large bowel using a flexible endoscope | 93 | $11,214 | $121 |
| Test for tone and sensation of rectum and anus | 14 | $8,454 | $604 |
| Return visit (30+ min) | 59 | $7,527 | $102 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $5,970 | $213 |
| New patient visit (45+ min) | 29 | $4,329 | $149 |
| Study of rectum sensitivity and function | 14 | $4,124 | $295 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $2,538 | $79 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 151 | $745 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $509 | $21 |
2020: 9 services
| Long return visit (40+ min) | 40 | $7,591 | $136 |
| Biopsy of large bowel using a flexible endoscope | 52 | $7,190 | $138 |
| Return visit (30+ min) | 57 | $7,006 | $102 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $4,616 | $231 |
| New patient visit (45+ min) | 28 | $3,723 | $133 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,255 | $217 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,081 | $77 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 102 | $525 | $5 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 11 | $150 | $14 |
2019: 9 services
| Long return visit (40+ min) | 66 | $10,461 | $131 |
| Biopsy of large bowel using a flexible endoscope | 71 | $9,137 | $129 |
| New patient visit (45+ min) | 61 | $8,569 | $140 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 32 | $7,049 | $220 |
| Return visit (30+ min) | 36 | $3,861 | $97 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $3,853 | $90 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,645 | $214 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,433 | $215 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 127 | $665 | $5 |
2018: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $23,503 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $14,467 | $174 |
| Long return visit (40+ min) | 105 | $12,481 | $86 |
| Biopsy of large bowel using a flexible endoscope | 33 | $4,711 | $143 |
| Long return visit (40+ min) | 33 | $4,705 | $127 |
| New patient visit (45+ min) | 32 | $4,102 | $128 |
| New patient visit (60+ min) | 31 | $3,788 | $122 |
| New patient visit (45+ min) | 35 | $3,433 | $98 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $3,424 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,698 | $112 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,311 | $210 |
| Imaging of digestive tract done from the inside of the digestive tract | 19 | $2,282 | $114 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | $1,497 | $136 |
| Return visit (30+ min) | 14 | $1,353 | $85 |
| Return visit (30+ min) | 17 | $1,288 | $64 |
| Study of rectum sensitivity and function | 15 | $1,099 | $73 |
| Study of esophagus to assess movement | 16 | $878 | $55 |
| Test for tone and sensation of rectum and anus | 15 | $607 | $40 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 18 | $143 | $8 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 34 | $139 | $4 |
2017: 25 services
| Long return visit (40+ min) | 161 | $20,921 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $18,612 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $12,300 | $181 |
| New patient visit (60+ min) | 70 | $8,717 | $125 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 71 | $5,844 | $79 |
| New patient visit (45+ min) | 53 | $5,421 | $102 |
| Biopsy of large bowel using a flexible endoscope | 35 | $4,797 | $137 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,444 | $114 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,185 | $212 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 19 | $2,514 | $126 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,226 | $202 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,214 | $76 |
| New patient visit (45+ min) | 15 | $2,205 | $147 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,166 | $155 |
| Long return visit (40+ min) | 16 | $2,069 | $129 |
| Study of esophagus to assess movement | 34 | $2,037 | $60 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $1,588 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,422 | $65 |
| Study of rectum sensitivity and function | 16 | $1,305 | $82 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,196 | $100 |
| Test for tone and sensation of rectum and anus | 16 | $722 | $45 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $677 | $28 |
| Study of esophageal sensation by balloon distension | 13 | $643 | $46 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 59 | $283 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $120 | $11 |
2016: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $21,986 | $93 |
| Long return visit (40+ min) | 153 | $20,752 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $17,778 | $181 |
| New patient visit (60+ min) | 83 | $12,164 | $147 |
| Biopsy of large bowel using a flexible endoscope | 42 | $6,739 | $160 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 55 | $4,434 | $81 |
| New patient visit (45+ min) | 36 | $4,066 | $113 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $2,271 | $95 |
| Imaging of digestive tract done from the inside of the digestive tract | 13 | $2,270 | $175 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,908 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,746 | $116 |
| Study of esophagus to assess movement | 27 | $1,653 | $61 |
| Study of rectum sensitivity and function | 19 | $1,546 | $81 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | $1,479 | $134 |
| Study of esophageal sensation by balloon distension | 12 | $1,021 | $79 |
| Test for tone and sensation of rectum and anus | 19 | $864 | $45 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $565 | $40 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 11 | $102 | $9 |
2015: 17 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $23,786 | $93 |
| Long return visit (40+ min) | 107 | $20,828 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $20,021 | $182 |
| New patient visit (60+ min) | 66 | $11,858 | $180 |
| Long return visit (40+ min) | 61 | $6,340 | $99 |
| Biopsy of large bowel using a flexible endoscope | 25 | $4,737 | $189 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,610 | $109 |
| New patient visit (60+ min) | 17 | $2,572 | $151 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,151 | $98 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $2,125 | $177 |
| New patient visit (45+ min) | 13 | $1,731 | $133 |
| Study of rectum sensitivity and function | 18 | $1,468 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,432 | $65 |
| Study of esophagus to assess movement | 23 | $1,432 | $62 |
| Test for tone and sensation of rectum and anus | 19 | $878 | $46 |
| Biofeedback training, perineal muscles, anorectal or urethral sphincter | 11 | $877 | $40 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 24 | $223 | $9 |
2014: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $6,312 | $93 |
| New patient visit (60+ min) | 33 | $6,105 | $185 |
| Long return visit (40+ min) | 30 | $4,601 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,975 | $181 |
Drugs they prescribed that Part D paid
$456,862
Pharmacies billed $456,862 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 785) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
528 generic and 257 brand-name prescriptions · $456,862 in drug cost · 23 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Motegrity | 63 | $55,712 | $884 |
| Linzess | 65 | $54,295 | $835 |
| Sod Sulf-Potass Sulf-Mag Sulf | 146 | $9,288 | $64 |
| Lubiprostone | 29 | $5,805 | $200 |
| Omeprazole | 63 | $986 | $16 |
See all 12 drugs
| Motegrity | 63 | $55,712 | $884 |
| Linzess | 65 | $54,295 | $835 |
| Sod Sulf-Potass Sulf-Mag Sulf | 146 | $9,288 | $64 |
| Lubiprostone | 29 | $5,805 | $200 |
| Omeprazole | 63 | $986 | $16 |
| Pantoprazole | 65 | $902 | $14 |
| Nortriptyline | 30 | $596 | $20 |
| Peg 3350-Electrolyte | 28 | $590 | $21 |
| Sucralfate | 16 | $555 | $35 |
| Famotidine | 36 | $333 | $9 |
| Duloxetine | 12 | $260 | $22 |
| Ondansetron Odt | 14 | $169 | $12 |
Year by year
| 2024 | 785 | 299 | 0% (0) | 33% | $456,862 |
| 2023 | 791 | 283 | 0% (0) | 34% | $461,571 |
| 2022 | 721 | 224 | 0% (0) | 40% | $624,669 |
| 2021 | 706 | 244 | None | None | $357,706 |
| 2020 | 454 | 185 | None | 41% | $200,245 |
| 2019 | 715 | 293 | None | 36% | $186,519 |
| 2018 | 1,250 | 274 | None | 24% | $369,455 |
| 2017 | 1,278 | 273 | 1% (12) | None | $243,084 |
| 2016 | 1,012 | 202 | 2% (15) | None | $139,681 |
| 2015 | 593 | 161 | None | None | $63,614 |
| 2014 | 198 | 47 | None | 32% | $18,284 |
| 2013 | 194 | 27 | None | 19% | $7,916 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Creon | 14 | $51,066 | $3,648 |
| Linzess | 58 | $47,639 | $821 |
| Motegrity | 50 | $40,614 | $812 |
| Lubiprostone | 31 | $14,589 | $471 |
| Sod Sulf-Potass Sulf-Mag Sulf | 120 | $9,440 | $79 |
| Bethanechol Chloride | 17 | $1,727 | $102 |
| Pantoprazole | 88 | $1,722 | $20 |
| Omeprazole | 68 | $1,360 | $20 |
| Hydrocortisone | 13 | $1,030 | $79 |
| Nortriptyline | 33 | $711 | $22 |
| Peg 3350-Electrolyte | 27 | $612 | $23 |
| Famotidine | 29 | $481 | $17 |
| Promethazine | 17 | $453 | $27 |
| Entecavir | 12 | $273 | $23 |
| Levothyroxine | 11 | $57 | $5 |
2022: 18 drugs
| Humira | 11 | $78,131 | $7,103 |
| Creon | 15 | $69,686 | $4,646 |
| Motegrity | 54 | $34,864 | $646 |
| Linzess | 43 | $33,110 | $770 |
| Lubiprostone | 20 | $13,332 | $667 |
| Suprep | 79 | $9,130 | $116 |
| Sucralfate | 22 | $8,627 | $392 |
| Omeprazole | 51 | $1,315 | $26 |
| Pantoprazole | 67 | $1,081 | $16 |
| Famotidine | 22 | $669 | $30 |
| Ondansetron Odt | 11 | $498 | $45 |
| Nortriptyline | 28 | $470 | $17 |
| Peg 3350-Electrolyte | 16 | $357 | $22 |
| Amitriptyline | 11 | $351 | $32 |
| Entecavir | 11 | $300 | $27 |
| Metoclopramide | 21 | $99 | $5 |
| Lovastatin | 11 | $31 | $3 |
| Lactulose | 13 | $14 | $1 |
2021: 22 drugs
| Humira | 13 | $151,760 | $11,674 |
| Motegrity | 36 | $28,136 | $782 |
| Linzess | 17 | $18,019 | $1,060 |
| Suprep | 112 | $12,383 | $111 |
| Amitiza | 16 | $7,732 | $483 |
| Clenpiq | 15 | $2,417 | $161 |
| Entecavir | 18 | $1,598 | $89 |
| Omeprazole | 45 | $1,401 | $31 |
| Pantoprazole | 80 | $1,129 | $14 |
| Pyridostigmine | 13 | $803 | $62 |
| Bethanechol Chloride | 11 | $693 | $63 |
| Ondansetron Odt | 12 | $548 | $46 |
| Diphenoxylate-Atropine | 14 | $443 | $32 |
| Duloxetine | 15 | $417 | $28 |
| Dicyclomine | 12 | $374 | $31 |
| Peg 3350-Electrolyte | 19 | $336 | $18 |
| Famotidine | 15 | $287 | $19 |
| Mirtazapine | 11 | $209 | $19 |
| Amitriptyline | 12 | $186 | $16 |
| Nortriptyline | 18 | $179 | $10 |
| Isosorbide Mononitrate Er | 11 | $108 | $10 |
| Ondansetron | 12 | $49 | $4 |
2020: 11 drugs
| Motegrity | 24 | $18,794 | $783 |
| Linzess | 19 | $16,149 | $850 |
| Amitiza | 22 | $10,110 | $460 |
| Suprep | 81 | $8,546 | $106 |
| Entecavir | 16 | $1,795 | $112 |
| Omeprazole | 28 | $650 | $23 |
| Pantoprazole | 37 | $548 | $15 |
| Nortriptyline | 13 | $247 | $19 |
| Famotidine | 12 | $138 | $12 |
| Isosorbide Mononitrate Er | 13 | $55 | $4 |
| Atenolol | 12 | $13 | $1 |
2019: 18 drugs
| Linzess | 23 | $21,402 | $931 |
| Amitiza | 33 | $17,468 | $529 |
| Suprep | 120 | $12,007 | $100 |
| Dexilant | 17 | $9,495 | $559 |
| Erythromycin | 22 | $8,286 | $377 |
| Movantik | 11 | $6,707 | $610 |
| Pantoprazole | 66 | $1,435 | $22 |
| Pyridostigmine | 12 | $1,255 | $105 |
| Omeprazole | 59 | $1,097 | $19 |
| Desipramine | 13 | $1,056 | $81 |
| Bethanechol Chloride | 19 | $970 | $51 |
| Ondansetron Odt | 22 | $700 | $32 |
| Sucralfate | 14 | $580 | $41 |
| Amitriptyline | 19 | $489 | $26 |
| Nortriptyline | 20 | $298 | $15 |
| Buspirone | 14 | $273 | $19 |
| Peg 3350-Electrolyte | 11 | $198 | $18 |
| Ranitidine | 16 | $131 | $8 |
2018: 35 drugs
| Linzess | 62 | $39,012 | $629 |
| Xifaxan | 12 | $19,182 | $1,599 |
| Amitiza | 21 | $12,584 | $599 |
| Budesonide Ec | 23 | $11,939 | $519 |
| Erythromycin | 24 | $9,087 | $379 |
| Dexilant | 19 | $9,023 | $475 |
| Suprep | 73 | $6,840 | $94 |
| Lyrica | 14 | $6,331 | $452 |
| Octreotide Acetate | 22 | $4,584 | $208 |
| Desipramine | 41 | $3,777 | $92 |
| Gabapentin | 33 | $2,286 | $69 |
| Duloxetine | 33 | $2,173 | $66 |
| Pyridostigmine | 29 | $1,868 | $64 |
| Pantoprazole | 130 | $1,846 | $14 |
| Azathioprine | 12 | $1,285 | $107 |
| Nortriptyline | 88 | $1,192 | $14 |
| Promethazine | 20 | $1,188 | $59 |
| Polyethylene Glycol 3350 | 49 | $1,078 | $22 |
| Ondansetron Odt | 34 | $951 | $28 |
| Omeprazole | 71 | $950 | $13 |
| Diphenoxylate-Atropine | 22 | $932 | $42 |
| Amitriptyline | 28 | $801 | $29 |
| Bethanechol Chloride | 11 | $767 | $70 |
| Diltiazem | 12 | $546 | $45 |
| Buspirone | 19 | $441 | $23 |
| Sucralfate | 19 | $425 | $22 |
| Mirtazapine | 16 | $362 | $23 |
| Famotidine | 26 | $339 | $13 |
| Neomycin Sulfate | 11 | $294 | $27 |
| Ranitidine | 24 | $287 | $12 |
| Prednisone | 13 | $138 | $11 |
| Isosorbide Mononitrate Er | 12 | $102 | $8 |
| Imipramine | 11 | $99 | $9 |
| Citalopram Hbr | 11 | $97 | $9 |
| Trazodone | 14 | $69 | $5 |
2017: 34 drugs
| Linzess | 107 | $64,586 | $604 |
| Amitiza | 39 | $26,017 | $667 |
| Viberzi | 13 | $24,125 | $1,856 |
| Budesonide Ec | 20 | $15,033 | $752 |
| Dexilant | 12 | $5,519 | $460 |
| Suprep | 47 | $4,123 | $88 |
| Octreotide Acetate | 17 | $3,378 | $199 |
| Erythrocin Stearate | 12 | $3,262 | $272 |
| Gabapentin | 47 | $3,248 | $69 |
| Desipramine | 19 | $1,975 | $104 |
| Pyridostigmine | 29 | $1,913 | $66 |
| Ondansetron Odt | 53 | $1,851 | $35 |
| Azathioprine | 13 | $1,614 | $124 |
| Polyethylene Glycol 3350 | 60 | $1,487 | $25 |
| Nortriptyline | 80 | $1,085 | $14 |
| Pantoprazole | 72 | $955 | $13 |
| Diphenoxylate-Atropine | 24 | $942 | $39 |
| Amitriptyline | 23 | $878 | $38 |
| Sucralfate | 19 | $868 | $46 |
| Omeprazole | 51 | $736 | $14 |
| Mirtazapine | 26 | $614 | $24 |
| Duloxetine | 27 | $580 | $21 |
| Buspirone | 41 | $569 | $14 |
| Famotidine | 32 | $377 | $12 |
| Promethazine | 27 | $375 | $14 |
| Gavilyte-G | 31 | $355 | $11 |
| Ranitidine | 24 | $246 | $10 |
| Fluconazole | 11 | $237 | $22 |
| Metoclopramide | 22 | $227 | $10 |
| Dicyclomine | 15 | $191 | $13 |
| Peg-3350 and Electrolytes | 11 | $153 | $14 |
| Citalopram Hbr | 22 | $95 | $4 |
| Trazodone | 17 | $81 | $5 |
| Tramadol | 12 | $72 | $6 |
2016: 32 drugs
| Amitiza | 65 | $29,281 | $450 |
| Linzess | 39 | $18,520 | $475 |
| Budesonide Ec | 18 | $12,606 | $700 |
| Viberzi | 11 | $10,729 | $975 |
| Erythrocin Stearate | 21 | $9,768 | $465 |
| Carafate | 16 | $6,328 | $395 |
| Erythromycin | 13 | $4,465 | $343 |
| Esomeprazole Magnesium | 11 | $4,250 | $386 |
| Suprep | 33 | $2,750 | $83 |
| Azathioprine | 23 | $1,883 | $82 |
| Gabapentin | 54 | $1,737 | $32 |
| Ondansetron Odt | 55 | $1,530 | $28 |
| Desipramine | 18 | $1,434 | $80 |
| Sucralfate | 15 | $1,051 | $70 |
| Nortriptyline | 76 | $879 | $12 |
| Polyethylene Glycol 3350 | 17 | $710 | $42 |
| Pyridostigmine | 19 | $673 | $35 |
| Pantoprazole | 36 | $667 | $19 |
| Amitriptyline | 30 | $572 | $19 |
| Omeprazole | 36 | $562 | $16 |
| Bethanechol Chloride | 11 | $547 | $50 |
| Buspirone | 49 | $473 | $10 |
| Promethazine | 24 | $310 | $13 |
| Duloxetine | 17 | $297 | $17 |
| Peg-3350 and Electrolytes | 14 | $269 | $19 |
| Gavilyte-G | 17 | $234 | $14 |
| Citalopram Hbr | 38 | $205 | $5 |
| Ranitidine | 28 | $178 | $6 |
| Dicyclomine | 13 | $125 | $10 |
| Tramadol | 13 | $58 | $4 |
| Trazodone | 12 | $54 | $4 |
| Lorazepam | 15 | $51 | $3 |
2015: 15 drugs
| Amitiza | 37 | $11,744 | $317 |
| Erythromycin | 18 | $5,695 | $316 |
| Linzess | 16 | $4,907 | $307 |
| Moviprep | 18 | $1,454 | $81 |
| Duloxetine | 16 | $1,420 | $89 |
| Nortriptyline | 96 | $725 | $8 |
| Ondansetron Odt | 17 | $380 | $22 |
| Peg-3350 and Electrolytes | 17 | $313 | $18 |
| Gabapentin | 14 | $300 | $21 |
| Buspirone | 13 | $279 | $21 |
| Atorvastatin | 19 | $268 | $14 |
| Omeprazole | 11 | $171 | $16 |
| Pantoprazole | 14 | $159 | $11 |
| Amitriptyline | 12 | $138 | $11 |
| Citalopram Hbr | 29 | $90 | $3 |
2014: 2 drugs
| Atorvastatin | 16 | $223 | $14 |
| Metformin | 15 | $91 | $6 |
2013: 3 drugs
| Gabapentin | 12 | $371 | $31 |
| Omeprazole | 11 | $255 | $23 |
| Metformin | 14 | $78 | $6 |
Money from drug and device companies
$779 in 2025
| 2025 | 10 | 36 | None | $779 |
| 2024 | 2 | 6 | None | $150 |
| 2023 | 4 | 4 | $4,680 | $4,746 |
| 2022 | 3 | 3 | $2,050 | $2,064 |
| 2021 | 4 | 17 | $10,500 | $10,955 |
| 2020 | 4 | 12 | $13,950 | $15,366 |
| 2019 | 8 | 15 | $7,500 | $7,934 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Linzess | $287 | 16 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $99 | 4 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $96 | 3 payments
|
| Janssen Biotech | Tremfya | $74 | 3 payments
|
| Lilly USA | Omvoh | $61 | 2 payments
|
| Ardelyx | Ibsrela | $56 | 2 payments
|
See all 36 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-21 | Xifaxan | $25 |
| Ardelyx | Meals · 2025-12-18 | Ibsrela | $28 |
| Abbvie | Meals · 2025-12-05 | Linzess | $27 |
| Novo Nordisk | Meals · 2025-11-20 | Wegovy | $20 |
| Abbvie | Meals · 2025-11-19 | Linzess | $7 |
| Phathom Pharmaceuticals | Meals · 2025-11-05 | Voquezna | $22 |
| Celltrion USA | Meals · 2025-10-30 | Vegzelma | $21 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-24 | Xifaxan | $25 |
| Ardelyx | Meals · 2025-10-23 | Ibsrela | $28 |
| Madrigal Pharmaceuticals | Meals · 2025-09-24 | Rezdiffra | $35 |
| Abbvie | Meals · 2025-09-19 | None | $27 |
| Janssen Biotech | Meals · 2025-09-11 | Tremfya | $26 |
| Abbvie | Meals · 2025-09-09 | Creon | $8 |
| Abbvie | Meals · 2025-09-05 | Creon | $15 |
| Abbvie | Meals · 2025-09-05 | Linzess | $31 |
| Abbvie | Meals · 2025-08-22 | Linzess | $16 |
| Lilly USA | Meals · 2025-08-18 | Omvoh | $26 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $24 |
| Abbvie | Meals · 2025-08-07 | Viberzi | $29 |
| Abbvie | Meals · 2025-07-25 | Viberzi | $14 |
| Abbvie | Meals · 2025-07-14 | Creon | $9 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-07-08 | Xifaxan | $25 |
| Abbvie | Meals · 2025-06-28 | Viberzi | $9 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-06-23 | Xifaxan | $25 |
| Intercept Pharmaceuticals | Meals · 2025-06-16 | Ocaliva | $19 |
| Madrigal Pharmaceuticals | Meals · 2025-06-10 | Rezdiffra | $28 |
| Abbvie | Meals · 2025-05-27 | Linzess | $15 |
| Janssen Biotech | Meals · 2025-04-29 | Tremfya | $24 |
| Abbvie | Meals · 2025-04-16 | Creon | $14 |
| Lilly USA | Meals · 2025-04-07 | Omvoh | $34 |
| Abbvie | Meals · 2025-03-25 | Creon | $23 |
| Abbvie | Meals · 2025-03-21 | Creon | $14 |
| Madrigal Pharmaceuticals | Meals · 2025-03-17 | Rezdiffra | $32 |
| Phathom Pharmaceuticals | Meals · 2025-03-04 | Voquezna | $22 |
| Phathom Pharmaceuticals | Meals · 2025-03-04 | Voquezna | $2 |
| Abbvie | Meals · 2025-01-22 | Linzess | $30 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $150
| Abbvie | Creon | $85 | 4 payments
|
| Lilly USA | Omvoh | $64 | 2 payments
|
2023: $4,746
| Genzyme | Dupixent | $3,330 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $1,350 | 1 payment
|
| Veloxis Pharmaceuticals | Envarsus | $50 | 1 payment
|
| Nestle Healthcare Nutrition | Vowst | $16 | 1 payment
|
2022: $2,064
| Ironwood Pharmaceuticals | Linzess | $1,350 | 1 payment
|
| Mahana Therapeutics | None | $700 | 1 payment
|
| Celgene | Zeposia | $14 | 1 payment
|
2021: $10,955
| AbbVie | Linzess | $6,379 | 9 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $4,200 | 3 payments
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $363 | 4 payments
|
| Ironwood Pharmaceuticals | Linzess | $13 | 1 payment
|
2020: $15,366
| Takeda Pharmaceuticals U.S.A. | Motegrity | $12,199 | 8 payments
|
| AbbVie | Linzess | $2,100 | 2 payments
|
| Allergan | Linzess | $1,050 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $17 | 1 payment
|
2019: $7,934
| Salix Pharmaceuticals a division of Bausch Health US | Plenvu | $4,555 | 3 payments
|
| Allergan | Linzess | $3,247 | 6 payments
|
| Covidien LP | Barrx | $35 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $24 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $23 | 1 payment
|
| AbbVie | Humira | $18 | 1 payment
|
| Braintree Laboratories | Motofen | $17 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $15 | 1 payment
|
Professional record
- NPI
- 1487831145
- Licence
- CA A102503California A102503: Current · expires 2027-07-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir Fl 2, Los Altos, CA, 94022
- NPI first listed
- 2008-01-24
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.